PAG
JAZZ icon

Private Advisor Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Private Advisor Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$250K Sell
1,039
-1,532
-60% -$336K ﹤0.01% 2214
2026
Q1 		$486K Buy
2,571
+21
+0.8% +$3.67K ﹤0.01% 1879
2025
Q4 		$434K Sell
2,550
-197
-7% -$30.2K ﹤0.01% 1916
2025
Q3 		$362K Sell
2,747
-498
-15% -$59.7K ﹤0.01% 1961
2025
Q2 		$344K Sell
3,245
-21
-0.6% -$2.28K ﹤0.01% 1901
2025
Q1 		$405K Sell
3,266
-1,657
-34% -$216K ﹤0.01% 1714
2024
Q4 		$606K Sell
4,923
-2,793
-36% -$329K ﹤0.01% 1462
2024
Q3 		$860K Buy
7,716
+5,437
+239% +$596K 0.01% 1313
2024
Q2 		$243K Sell
2,279
-880
-28% -$96.8K ﹤0.01% 2031
2024
Q1 		$380K Buy
3,159
+192
+6% +$23.5K ﹤0.01% 1684
2023
Q4 		$365K Buy
2,967
+979
+49% +$122K ﹤0.01% 1661
2023
Q3 		$257K Sell
1,988
-484
-20% -$64.5K ﹤0.01% 1728
2023
Q2 		$306K Sell
2,472
-855
-26% -$115K ﹤0.01% 1618
2023
Q1 		$487K Buy
+3,327
New +$492K ﹤0.01% 1350
2022
Q4 		– Sell
-3,723
Closed -$496K – 1821
2022
Q3 		$496K Buy
3,723
+151
+4% +$23K 0.01% 1237
2022
Q2 		$557K Buy
3,572
+61
+2% +$9.39K 0.01% 1352
2022
Q1 		$547K Buy
+3,511
New +$510K ﹤0.01% 1383
2020
Q3 		– Sell
-127
Closed -$14K – 2535
2020
Q2 		$14K Buy
+127
New +$14K ﹤0.01% 2755
2018
Q3 		– Sell
-5,516
Closed -$951K – 1626
2018
Q2 		$951K Buy
+5,516
New +$902K 0.02% 500
2017
Q2 		– Sell
-1,525
Closed -$215K – 1426
2017
Q1 		$215K Buy
+1,525
New +$199K 0.01% 1238
2014
Q1 		– Sell
-7,075
Closed -$895K – 822
2013
Q4 		$895K Buy
+7,075
New +$732K 0.1% 247

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Private Advisor Group's JAZZ Position: Q2 2026 in Review

Private Advisor Group reduced its Jazz Pharmaceuticals (JAZZ) stake by 60% in Q2 2026, selling an estimated $336K and leaving 1,039 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #2214.

Private Advisor Group first reported a position in JAZZ in Q4 2013 and has held it in 21 quarters since. The position peaked at $951K in Q2 2018. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Private Advisor Group held 1,039 shares of Jazz Pharmaceuticals worth $250K as of Q2 2026.
  • Private Advisor Group sold 1,532 Jazz Pharmaceuticals shares in Q2 2026, an estimated $336K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #2214 holding.
  • Private Advisor Group first reported a position in Jazz Pharmaceuticals in Q4 2013 and has held it in 21 quarters since.
  • Private Advisor Group's Jazz Pharmaceuticals position peaked at $951K in Q2 2018.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.